Occudo Quantitative Strategies LP Esperion Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $80,785 - $120,510	14,823 Added 28.6%	66,652 $447,000
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $312,845 - $437,458	-65,586 Reduced 55.86%	51,829 $330,000
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $221,585 - $368,867	66,343 Added 129.9%	117,415 $545,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $245,656 - $608,778	51,072 New	51,072 $255,000
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $120,011 - $226,158	-10,583 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $205,310 - $303,837	10,583 New	10,583 $224,000
Q1 2021 May 14, 2021	SELL	$25.12 - $36.89 $364,742 - $535,642	-14,520 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $351,384 - $519,235	14,520 New	14,520 $378,000

206

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $156M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.